G. J. Del-zoppo and T. Mabuchi, Cerebral Microvessel Responses to Focal Ischemia, Journal of Cerebral Blood Flow & Metabolism, vol.22, pp.879-894, 2003.
DOI : 10.1097/01.WCB.0000078322.96027.78

S. Fukuda, Focal Cerebral Ischemia Induces Active Proteases That Degrade Microvascular Matrix, Stroke, vol.35, issue.4, pp.998-1004, 2004.
DOI : 10.1161/01.STR.0000119383.76447.05
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2979008

T. Aoki, Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9 Expression During Reperfusion Injury: Mechanical Versus Embolic Focal Ischemia in Spontaneously Hypertensive Rats, Stroke, vol.33, issue.11, pp.2711-2717, 2002.
DOI : 10.1161/01.STR.0000033932.34467.97

S. R. Lee, Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators, Neuroscience Letters, vol.417, issue.1, pp.1-5, 2007.
DOI : 10.1016/j.neulet.2007.01.017

C. S. Kidwell, Thrombolytic Toxicity: Blood Brain Barrier Disruption in Human Ischemic Stroke, Cerebrovascular Diseases, vol.25, issue.4, pp.338-343, 2008.
DOI : 10.1159/000118379

E. J. Su, Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke, Nature Medicine, vol.276, issue.7, pp.731-737, 2008.
DOI : 10.1038/nm1787

R. Polavarapu, Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit, Blood, vol.109, issue.8, pp.3270-3278, 2007.
DOI : 10.1182/blood-2006-08-043125

R. Polavarapu, Regulated Intramembrane Proteolysis of the Low-Density Lipoprotein Receptor-Related Protein Mediates Ischemic Cell Death, The American Journal of Pathology, vol.172, issue.5, pp.1355-1362, 2008.
DOI : 10.2353/ajpath.2008.070975

L. F. Chen and W. C. Greene, Shaping the nuclear action of NF-??B, Nature Reviews Molecular Cell Biology, vol.5, issue.5, pp.392-401, 2004.
DOI : 10.1038/nrm1368

S. Shishodia and B. B. Aggarwal, Nuclear Factor-??B Activation Mediates Cellular Transformation, Proliferation, Invasion Angiogenesis and Metastasis of Cancer, Cancer Treat. Res, vol.119, pp.139-173, 2004.
DOI : 10.1007/1-4020-7847-1_8

H. L. Pahl, Activators and target genes of Rel/NF-??B transcription factors, Oncogene, vol.18, issue.49, pp.6853-6866, 1999.
DOI : 10.1038/sj.onc.1203239

A. Schneider, NF-kB is activated and promotes cell death in focal cerebral ischemia, Nat. Med, vol.5, pp.554-559, 1999.

D. Stephenson, Transcription factor nuclear factor-kB is activated in neurons after focal cerebral ischemia, J. Cereb. Blood Flow Metab, vol.20, pp.592-603, 2000.

M. P. Mattson and S. Camandola, NF-??B in neuronal plasticity and neurodegenerative disorders, Journal of Clinical Investigation, vol.107, issue.3, pp.247-254, 2001.
DOI : 10.1172/JCI11916

M. P. Mattson, Roles of Nuclear Factor ??B in Neuronal Survival and Plasticity, Journal of Neurochemistry, vol.13, issue.2, pp.443-456, 2000.
DOI : 10.1046/j.1471-4159.2000.740443.x

W. Zhang, Neuronal Activation of NF-??B Contributes to Cell Death in Cerebral Ischemia, Journal of Cerebral Blood Flow & Metabolism, vol.23, issue.1, pp.30-40, 2005.
DOI : 10.1038/jcbfm.1990.47

L. Xu, Recombinant adenoviral expression of dominant negative I??B?? protects brain from cerebral ischemic injury, Biochemical and Biophysical Research Communications, vol.299, issue.1, pp.14-17, 2002.
DOI : 10.1016/S0006-291X(02)02573-1

X. Zhang, Tissue-Type Plasminogen Activator and the Low-Density Lipoprotein Receptor-Related Protein Mediate Cerebral Ischemia-Induced Nuclear Factor-??B Pathway Activation, The American Journal of Pathology, vol.171, issue.4, pp.1281-1290, 2007.
DOI : 10.2353/ajpath.2007.070472

G. Yu, Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-??B-dependent manner, Blood, vol.105, issue.9, pp.3545-3551, 2005.
DOI : 10.1182/blood-2004-07-2617

K. Hu, Tissue-type Plasminogen Activator Acts as a Cytokine That Triggers Intracellular Signal Transduction and Induces Matrix Metalloproteinase-9 Gene Expression, Journal of Biological Chemistry, vol.281, issue.4, pp.2120-2127, 2006.
DOI : 10.1074/jbc.M504988200

L. Park, Key role of tissue plasminogen activator in neurovascular coupling, Proceedings of the National Academy of Sciences, vol.105, issue.3, pp.1073-1078, 2008.
DOI : 10.1073/pnas.0708823105

X. Wang, Lipoprotein receptor???mediated induction of matrix metalloproteinase by tissue plasminogen activator, Nature Medicine, vol.9, issue.10, pp.1313-1317, 2003.
DOI : 10.1038/nm926

P. A. Lapchak, Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)-Induced Hemorrhage After Thromboembolic Stroke Editorial Comment, Stroke, vol.31, issue.12, pp.3034-3040, 2000.
DOI : 10.1161/01.STR.31.12.3034

K. Benchenane, Tissue-Type Plasminogen Activator Crosses the Intact Blood-Brain Barrier by Low-Density Lipoprotein Receptor-Related Protein-Mediated Transcytosis, Circulation, vol.111, issue.17, pp.2241-2249, 2005.
DOI : 10.1161/01.CIR.0000163542.48611.A2
URL : https://hal.archives-ouvertes.fr/hal-00542121

K. Benchenane, Oxygen Glucose Deprivation Switches the Transport of tPA Across the Blood-Brain Barrier From an LRP-Dependent to an Increased LRP-Independent Process, Stroke, vol.36, issue.5, pp.1065-1070, 2005.
DOI : 10.1161/01.STR.0000163050.39122.4f
URL : https://hal.archives-ouvertes.fr/hal-00542010

K. Benchenane, Equivocal roles of tissue-type plasminogen activator in stroke-induced injury, Trends in Neurosciences, vol.27, issue.3, pp.155-160, 2004.
DOI : 10.1016/j.tins.2003.12.011

A. L. Samson and R. L. Medcalf, Tissue-Type Plasminogen Activator: A Multifaceted Modulator of Neurotransmission and Synaptic Plasticity, Neuron, vol.50, issue.5, pp.673-678, 2006.
DOI : 10.1016/j.neuron.2006.04.013

S. E. Tsirka, Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator, Nature, vol.377, issue.6547, pp.340-344, 1995.
DOI : 10.1038/377340a0

Z. L. Chen and S. Strickland, Neuronal Death in the Hippocampus Is Promoted by Plasmin-Catalyzed Degradation of Laminin, Cell, vol.91, issue.7, pp.917-925, 1997.
DOI : 10.1016/S0092-8674(00)80483-3

J. J. Sheehan, Proteolytic Activation of Monocyte Chemoattractant Protein-1 by Plasmin Underlies Excitotoxic Neurodegeneration in Mice, Journal of Neuroscience, vol.27, issue.7, pp.1738-1745, 2007.
DOI : 10.1523/JNEUROSCI.4987-06.2007

M. Ferná-ndez-monreal, Arginine 260 of the Amino-terminal Domain of NR1 Subunit Is Critical for Tissue-type Plasminogen Activator-mediated Enhancement of N-Methyl-D-aspartate Receptor Signaling, Journal of Biological Chemistry, vol.279, issue.49, pp.50850-50856, 2004.
DOI : 10.1074/jbc.M407069200

K. Benchenane, Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory, Journal of Cell Science, vol.120, issue.4, pp.578-585, 2007.
DOI : 10.1242/jcs.03354
URL : https://hal.archives-ouvertes.fr/hal-00178289

T. Matys and S. Strickland, Tissue plasminogen activator and NMDA receptor cleavage, Nature Medicine, vol.9, issue.4, pp.371-372, 2003.
DOI : 10.1038/nm0403-371

M. Kvajo, Regulation of Brain Proteolytic Activity Is Necessary for the In Vivo Function of NMDA Receptors, Journal of Neuroscience, vol.24, issue.43, pp.9734-9743, 2004.
DOI : 10.1523/JNEUROSCI.3306-04.2004

A. L. Samson, Tissue-type plasminogen activator requires a co-receptor to enhance N-Methyl-D-Aspartate receptor function, J. Neurochem, vol.107, pp.1091-1101, 2008.

R. Pawlak, From The Cover: Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors, Proceedings of the National Academy of Sciences, vol.102, issue.2, pp.443-448, 2005.
DOI : 10.1073/pnas.0406454102

E. H. Norris and S. Strickland, Modulation of NR2B-regulated contextual fear in the hippocampus by the tissue plasminogen activator system, Proceedings of the National Academy of Sciences, vol.104, issue.33, pp.13473-13478, 2007.
DOI : 10.1073/pnas.0705848104

S. R. Parathath, Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice, Journal of Cell Science, vol.119, issue.2, pp.339-349, 2006.
DOI : 10.1242/jcs.02734

A. M. Martin, -Methyl-D-aspartate Receptors, Journal of Biological Chemistry, vol.283, issue.18, pp.12004-12013, 2008.
DOI : 10.1074/jbc.M707607200
URL : https://hal.archives-ouvertes.fr/edutice-00109613

M. G. Medina, Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation, The EMBO Journal, vol.96, issue.9, pp.1706-1716, 2005.
DOI : 10.1038/sj.emboj.7600650

D. Liu, Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C, Nature Medicine, vol.93, issue.12, p.1379, 2004.
DOI : 10.1038/ni0503-404

G. Liot, Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity, Journal of Neurochemistry, vol.20, issue.5, pp.1458-1464, 2006.
DOI : 10.1016/j.expneurol.2004.05.032
URL : https://hal.archives-ouvertes.fr/inserm-01296667

H. Y. Lee, Non-proteolytic neurotrophic effects of tissue plasminogen activator on cultured mouse cerebrocortical neurons, Journal of Neurochemistry, vol.20, issue.5, pp.1236-1247, 2007.
DOI : 10.1111/j.1471-4159.2004.02509.x

P. T. Pang, Cleavage of proBDNF by tPA/Plasmin Is Essential for Long-Term Hippocampal Plasticity, Science, vol.306, issue.5695, pp.487-491, 2004.
DOI : 10.1126/science.1100135

B. M. Demaerschalk, Development of a Metropolitan Matrix of Primary Stroke Centers: The Phoenix Experience, Stroke, vol.39, issue.4, pp.1246-1253
DOI : 10.1161/STROKEAHA.107.500678

A. V. Alexandrov, Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke, New England Journal of Medicine, vol.351, issue.21, p.2170, 2004.
DOI : 10.1056/NEJMoa041175

P. Khatri, Methodology of the Interventional Management of Stroke III Trial, International Journal of Stroke, vol.38, issue.2, pp.130-137, 2008.
DOI : 10.1056/NEJM199512143332401

J. P. Lopez-atalaya, Toward Safer Thrombolytic Agents in Stroke: Molecular Requirements for NMDA Receptor-Mediated Neurotoxicity, Journal of Cerebral Blood Flow & Metabolism, vol.384, issue.6, pp.1212-1221, 2008.
DOI : 10.1056/NEJM199512143332401

G. T. Liberatore, Vampire Bat Salivary Plasminogen Activator (Desmoteplase): A Unique Fibrinolytic Enzyme That Does Not Promote Neurodegeneration, Stroke, vol.34, issue.2, pp.537-543, 2003.
DOI : 10.1161/01.STR.0000049764.49162.76

J. P. López-atalaya, Recombinant Desmodus rotundus Salivary Plasminogen Activator Crosses the Blood-Brain Barrier Through a Low-Density Lipoprotein Receptor-Related Protein-Dependent Mechanism Without Exerting Neurotoxic Effects, Stroke, vol.38, issue.3, pp.1036-1043, 2007.
DOI : 10.1161/01.STR.0000258100.04923.84

C. Reddrop, Vampire Bat Salivary Plasminogen Activator (Desmoteplase) Inhibits Tissue-Type Plasminogen Activator-Induced Potentiation of Excitotoxic Injury, Stroke, vol.36, issue.6, pp.1241-1246, 2005.
DOI : 10.1161/01.STR.0000166050.84056.48

W. M. Armstead, Neutralizing the neurotoxic effects of exogenous and endogenous tPA, Nature Neuroscience, vol.49, issue.9, pp.1150-1155, 2006.
DOI : 10.1016/S0014-2999(02)02686-9

T. Cheng, Activated protein C inhibits tissue plasminogen activator???induced brain hemorrhage, Nature Medicine, vol.259, issue.11, pp.1278-1285, 2006.
DOI : 10.1038/nm1498

J. H. Griffin, Activated protein C, Journal of Thrombosis and Haemostasis, vol.234, pp.73-80, 2007.
DOI : 10.1111/j.1538-7836.2007.02491.x

S. Thorsen, Differences in the binding to fibrin of urokinase and tissue plasminogen activator, Thromb. Diath. Haemorrh, vol.28, p.65, 1972.

M. Kaneko, Interactions between the Finger and Kringle-2 Domains of Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor-11, The Journal of Biochemistry, vol.111, issue.2, pp.244-248, 1992.
DOI : 10.1093/oxfordjournals.jbchem.a123744